European Journal of Nuclear Medicine and Molecular Imaging

ISSN: 1619-7070

Journal Guideline

European Journal of Nuclear Medicine and Molecular Imaging Q1 Unclaimed

Springer Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease.The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies. The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor. This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members are entitled to access the full-text electronic version of the journal via the society's website www.eanm.org in the restricted members' area.Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with the journals EJNMMI Physics, EJNMMI Research, EJNMMI Radiopharmacy and Chemistry, and the European Journal of Hybrid Imaging.EJNMMI is part of the EJNMMI journal family. Further details can be found at https://www.springeropen.com/p/nuclear-medicine including the winners of the Annual EANM Springer Award. Why publish with us As Europe's leading journal in our field, we welcome international submissions from the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. Our coverage extends to physics, dosimetry, radiation biology, radiochemistry and pharmacy. We offer high quality peer review by experts in the field, and our highly cited and downloaded articles help ensure global visibility for your work. It has an SJR impact factor of 2,1.

European Journal of Nuclear Medicine and Molecular Imaging focuses its scope in these topics and keywords: petct, imaging, head, molecular, tumor, petmri, pet, fdopa, positron, patients, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Radiology, Nuclear Medicine and Imaging (Q1)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,1

SJR Impact factor

177

H Index

447

Total Docs (Last Year)

1271

Total Docs (3 years)

16318

Total Refs

8228

Total Cites (3 years)

997

Citable Docs (3 years)

6.37

Cites/Doc (2 years)

36.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1

Compare this journals

Aims and Scope

Best articles by citations

Dosimetry in leakage of 188 Re-DTPA during intracoronary balloon brachytherapy

Antisense imaging of epidermal growth factor-induced p21 WAF-1/CIP-1 gene expression in MDA-MB-468 human breast cancer xenografts

Undergraduate teaching of nuclear medicine in European universities

European Journal of Nuclear Medicine and Molecular Imaging manuscript processing goes online

Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET

PET/CT: a new imaging technology in nuclear medicine

PET/CT: a new road map

Rapid normalization of osseous FDG uptake following traumatic or surgical fractures

Information transfer from the USA and Europe to Latin America: current need and suitable methods

Important developments for the European Journal of Nuclear Medicine and Molecular Imaging

Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials

Practical use and implementation of PET in children in a hospital PET centre

SHOW MORE ARTICLES

[ 11 C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain

In vivo imaging of rat brain A 1 adenosine receptor occupancy by caffeine

Infection imaging using whole-body FDG-PET

Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes

Improvement of signal-to-noise ratio using iterative reconstruction in a 99m Tc-ECD split-dose injection protocol

Persistent non-specific FDG uptake on PET imaging following hip arthroplasty

Comparison of 16-frame and 8-frame gated SPET imaging for determination of left ventricular volumes and ejection fraction

Molecular imaging and molecular diagnostics: two sides of the same coin?

FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables

Enhanced washout of 99m Tc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123 I-BMIPP uptake and wall thickness determined by MRI

In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage

The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma